Project Grant R21HD115087
- The National Institute of Child Health and Human Development awarded Massachusetts General Hospital $466,740 on August 3, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate congenital diaphragmatic hernia (CDH) using fetal tracheal aspirates as a molecular and cellular window into hypoplastic lung development. The project will examine when an inflammatory signature—characterized by increased cytokeratin 5 and activated NFKB expression with...
- The National Institute of Child Health and Human Development, part of the Department of Health and Human Services National Institutes of Health, awarded $456,500 to The University of Texas Southwestern Medical Center on June 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award funds molecular characterization of human pregnancy-induced cervical epithelium through two research aims. First, the recipient will apply single-cell and spatial...
- The National Institute of Child Health and Human Development awarded Regents of the University of Michigan $603,157 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop engineered modular porous scaffolds for enhanced vascular integration in long-term tissue grafting. The award funds development of annealed porous grafts—next-generation ovarian tissue implants designed to restore ovarian endocrine function in patients with...
- The federal Project Grant award R03HD113887, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to investigate the role of the ZFHX4 gene in lung mesenchyme development and its potential implications for understanding the pathogenesis of lung hypoplasia in congenital diaphragmatic hernia (CDH). The $164,990 award, with a performance period from August 1, 2024 to...
- This $161,500 Project Grant was awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant is intended to establish basic science-clinical collaborations to understand the molecular mechanisms of heterotaxy, a severe form of congenital heart disease that affects 3-4% of patients with congenital heart defects. The funding will support research at the University of Virginia to...
- Federal Project Grant Award Summary Boston Children's Hospital received a $674,620 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective September 1, 2025 through August 31, 2027. The award supports investigator-initiated research to elucidate the genetic and developmental basis for coordinated limb growth and proportion regulation. The research employs integrated...
- The National Institute of Child Health and Human Development awarded The Ohio State University $157,500 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.HDR) to evaluate the dynamics of developmental tube morphogenesis. The recipient will construct and validate a computational framework combining mathematical modeling and image-based analysis to investigate how mechanical forces and genetic regulation coordinate biological tube formation and...
- This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is funding the development of a nanofiber patch for the treatment of pediatric tracheal stenosis, a life-threatening condition involving airway narrowing. The $154,000 award to Colorado State University aims to create a synthetic trachea patch that can maintain airway patency and regenerate cartilage-like...
- The National Institute of Child Health and Human Development awarded the University of Washington $128,169 under the Child Health and Human Development Extramural Research program (CFDA 93.865) on September 1, 2026, to conduct multi-omic dissection of early embryogenesis and neural tube defects using human gastruloids. The project integrates transcriptomics and proteomics to systematically profile gastruloid development, map protein interactomes, and model neural tube defects....
- The National Institute of Child Health and Human Development awarded Emory University $426,948 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop and validate artificial intelligence models that integrate electronic health record data to identify clinically meaningful subtypes of hypertensive disorders of pregnancy and predict disease onset before clinical diagnosis. The project will model longitudinal physiological changes and...
The National Institute of Child Health and Human Development, part of the Department of Health and Human Services, awarded Georgia TECH Research Corp $438,349 on August 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop a computational model integrating microstructural growth dynamics with preclinical data to advance congenital diaphragmatic hernia (CDH) patch repair. The project addresses the high recurrence rate of CDH surgical repairs, which exceed 30–50% within the first few years post-repair, largely due to rapid postnatal growth, mechanical failure at the patch-tissue interface, and alterations in tissue remodeling. Current mesh materials used for large diaphragmatic defects—including non-resorbable synthetic materials such as GORE-TEX and resorbable collagen-based biomeshes—lack CDH-specific preclinical or clinical testing. The recipient will develop a computational model that simulates interactions between mesh patches and growing pathological tissues by integrating experimental data from laboratory studies, animal models, and human cadaver tissue experiments. The model will predict how growth, material degradation, and tissue remodeling contribute to recurrence risk, enabling surgeons to better anticipate points of mechanical weakness and make informed patch-selection decisions. The period of performance runs from August 1, 2026, through July 31, 2028. Work is performed in Georgia. The award is classified as a Project Grant, an assistance type.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $438.3k | 7/28/26 |